SDF1β expression in renal cell carcinoma correlates with grading and infiltration by CD8+ T-cells

Anticancer Research

Volumn 31, Issue 9, 2011, Pages 2797-2803

  Wehler, T C ^a   Graf, C ^a   Altherr, K ^a   Zimmermann, T ^a   Brenner, W ^a   Thuroff, J W ^a   Biesterfeld, S ^a   Gockel, I ^b   Theobald, M ^a   Galle, P R ^a   Schimanski, Carl Christoph ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Grade; RCC; SDF1 ; T cell infiltration

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1BETA;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY CELL; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, RENAL CELL; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CXCL12; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED;

EID: 80051640864     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Landis SH, Murray T and Bolden S: Cancer statistics. CA Cancer J Clin 49(1): 8-31, 1999.
2. Patel PH, Chaganti RSK and Motzer RJ: Minireview: Targeted therapy for metastatic renal cell carcinoma. Br J Cancer 94: 614-619, 2006.
3. Amato RJ: Chemotherapy for renal cell carcinoma. Semin Oncol 27(2): 177-186, 2000.
4. Motzer RJ, Bander NH and Nanus DM: Renal cell carcinoma. New Engl J Med 335: 865-875, 1996.
5. Motzer RJ, Bacik J and Mazumdar M: Prognostic factors for survival of patients with stage IV renal cell carcinoma: Memorial Sloan-Kettering Cancer Center experience. Clin Cancer Res 10: 6302S-6303S, 2004.
6. McDermott DF: Immunotherapy of metastatic renal cell carcinoma. Cancer 115: 2298-2305, 2009.
7. Arya M and Patel HR: Expanding role of chemokines and their receptors in cancer. Expert Rev Anticancer Ther 3(6): 749-52, 2003.
8. Zlotnik A and Yoshile O: Chemokines: a new classification system and their role in immunity. Immunity 12(2): 121-127, 2000.
9. Murdoch C: CXCR4: chemokine receptor extraordinaire. Immunol Rev 177: 175-184, 2000.
10. Sallusto F and Bagglioni M: Chemokines and leukocyte traffic. Nature 392: 565-568, 1998.
11. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP and Strieter RM: The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167(12): 1676-1686, 2003.
12. Terada R, Yamamoto K, Hakoda T, Shimada N, Okano N, Baba N, Ninomiya Y, Gershwin ME and Shiratori Y: Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab Invest 83(5): 665-672, 2003.
13. Wald o, Pappo O, Safadi R, Dagan-Berger M, Beider K, Wald H, Franitza S, Weiss I, Avniel S, Boaz P, Hanna J, Zamir G, Eid A, Mandelboim O, Spengler U, Galun E and Peled A: Involvement of the CXCL12/CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus. Eur J Immunol 34(4): 1164-1174, 2004.
14. Nagasawa T, Kikutani H and Kishimoto T: Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci USA 91(6): 2305-2309, 1994.
15. Shirozu M, Nakano T, Inazawa J, Tashiro K, Tada H, Shinohara T and Honjo T: Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28(3): 495-500, 1995.
16. Zlotnik A: Chemokines and cancer. Int J Cancer 119: 2026-2029, 2006.
17. Schimanski CC, Schwald S, Simiantonaki N, Jayasinghe C, Gönner U, Wilsberg V, Junginger T, Berger MR, Galle PR and Moehler M: Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 11(5): 1743-1750, 2005.
18. Kato M, Kitayama J, Kazama S and Nagawa H: Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 5(5): R144-150, 2003.
19. Uchida D, Begum NM, Almofti A, Nakashiro K, Kawamata H, Tateishi Y, Hamakawa H, Yoshida H and Sato M: Possible role of stromal cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp Cell Res 290(2): 289-302, 2003.
20. Mori T, Doi R, Koizumi M, Toyoda E, Ito D, Kami K, Masui T, Fujimoto K, Tamamura H, Hiramatsu K, Fujii N and Imamura M: CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther 3(1): 29-37, 2004.
21. Pan J, Mestas J, Burdick MD, Phillips RJ, Thomas GV, Reckamp K, Belperio JA and Strieter RM: Stromal-derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis. Mol Cancer 5: 56, 2006.
22. Wehler TC, Graf C, Biesterfeld S, Brenner W, Schadt J, Gockel I, Berger MR, Thüroff JW, Galle PR, Moehler M and Schimanski CC: Strong expression of chemokine receptor CXCR4 by renal cell carcinoma correlates with advanced disease. J Oncol 2008: 626340, 2008.
23. Eble JN, Sauter G, Epstein JI and Sesterhenn IA: Pathology and genetics. Tumors of the urinary system and male genital organs. IARC Press, Lyon, 2004.
24. Kryczek I, Wei S, Keller E, Liu R and Zou W: Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 292(3): C987-995, 2007.
25. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verástegui E and Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824): 50-56, 2001.
26. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM, Hooper AT, Amano H, Avecilla ST, Heissig B, Hattori K, Zhang F, Hicklin DJ, Wu Y, Zhu Z, Dunn A, Salari H, Werb Z, Hackett NR, Crystal RG, Lyden D and Rafii S: Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12(5): 557-567, 2006.
27. Liang Z, Brooks J, Willard M, Liang K, Yoon Y, Kang S and Shim H: CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through AKT signaling pathway. Biochem Biophys Res Commun 359(3): 716-722, 2007.
28. Chinni SR, Sivalogan S, Dong Z, Filho JC, Deng X, Bonfil RD and Cher ML: CXCL12/CXCR4 signaling activates AKT-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate 66(1): 32-48, 2006.
29. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR and Polyak K: Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6(1): 17-32, 2004.
30. Wang J, Guan E, Roderiquez G, Calvert V, Alvarez R and Norcross MA: Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages. J Biol Chem 276(52): 49236-49243, 2001.
31. Cristillo AD, Highbarger HC, Dewar RL, Dimitrov DS, Golding H and Bierer BE: Up-regulation of HIV co-receptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element. FASEB J 16(5): 354-364, 2002.
32. Katoh M and Katoh M: Integrative genomic analyses of CXCR4: Transcriptional regulation of CXCR4 based on TGFβ, nodal, activin signalling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFII transcription factors. Int J Oncol 36: 415-420, 2010.
33. Moriuchi M, Moriuchi H, Turner W and Fauci AS: Cloning and analysis of the promoter region of CXCR4, a co-receptor for HIV-1 entry. J Immunol 159(9): 4322-4329, 1997.
34. Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ and Oppenheim JJ: Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154(4): 1125-1135, 1999.
35. Phillips RJ, Mestas J, Gharaee-Kermani M, Burdick MD, Sica A, Belperio JA, Keane MP and Strieter RM: Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1 alpha. J Biol Chem 280(23): 22473-22481, 2005.
36. Brigati C, Noonan DM, Albini A and Benelli R: Tumors and inflammatory infiltrates: Friends or foes? Clin Exp Metastasis 19(5): 247-258, 2002.
37. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS and McCauley LK: Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62(6): 1832-1837, 2002.
38. Barbero S, Bajetto A, Bonavia R, Porcile C, Piccioli P, Pirani P, Ravetti JL, Zona G, Spaziante R, Florio T and Schettini G: Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann NY Acad Sci 973: 60-69, 2002.
39. Burger M, Glodek A, Hartmann T, Schmitt-Gräff A, Silberstein LE, Fujii N, Kipps TJ and Burger JA: Functional expression of CXCR4 (CD184) on small cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene 22(50): 8093-8101, 2003.
40. Cardones AR, Murakami T and Hwang ST: CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res 63(20): 6751-6757, 2003.
41. Sun X, Wei L, Chen Q and Terek RM: CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression. Mol Cancer 9: 17, 2010.
42. Wagner PL, Hyjek E, Vazquez MF, Meherally D, Liu YF and Chadwick PA: CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg 137(5): 615-621, 2009.
43. Jiang YP, Wu XH, Shi B, Wu WX and Yin GR: Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol 103(1): 226-233, 2006.
44. Salmaggi A, Maderna E, Calatozzolo C, Gaviani P, Canazza A and Milanesi I: CXCL12, CXCR4 and CXCR7 expression in brain metastases. Cancer Biol Ther 8: 17, 2009.
45. Kang H, Watkins G, Parr C, Douglas-Jones A, Mansel RE and Jiang WG: Stromal cell-derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res 7(4): R402-410, 2005.
46. Mirisola V, Zuccarino A, Bachmeier BE, Sormani MP, Falter J, Nerlich A and Pfeffer U: CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival. Eur J Cancer 45(14): 2579-2587, 2009.
47. Dunussi-Joannopoulos K, Zuberek K, Runyon K, Hawley RG, Wong A, Erickson J, Herrmann S and Leonard JP: Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses. Blood 100(5): 1551-1558, 2002.
48. + T-cells in non-small cell lung cancer is associated with dedifferentiation of cancer cells, but not with prognosis. Tohoku J Exp Med 191(2): 113-118, 2002.
49. Vianello F, Papeta N, Chen T, Kraft P, White N, Hart WK, Kircher MF, Swart E, Rhee S, Palù G, Irimia D, Toner M, Weissleder R and Poznansky MC: Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T-cell chemorepulsion and escape from immune control. J Immunol 176(5): 2902-2911, 2006.
50. Liang Z, Wu H, Reddy S, Zhu A, Wang S, Blevins D, Yoon Y, Zhang Y and Shim H: Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA. Biochem Biophys Res Commun 363(3): 542-546, 2007.
51. Liang Z, Wu T, Lou H, Yu X, Taichman RS, Lau SK, Nie S, Umbreit J and Shim H: Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64(12): 4302-4308, 2004.
52. Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L and Shim H: Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 65(3): 967-971, 2005.
53. Balkwill F and Mantovani A: Inflammation and cancer: Back to Virchow? Lancet 357(9255): 539-545, 2001.